Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Dental biomaterials are specialized fabricated structured instruments that are designed to be used in dentistry. Their main focus is replacement and enhancement of missing tissues due to some disease or accidents and also to restore its normal function. Dental biomaterials include the natural tissues and biocompatible synthetic materials that are used to restore decayed, damaged or fractured teeth. Likewise, natural dental tissues include enamel, dentin, cementum, bone, and other intraoral tissues. Biocompatible synthetic dental material groups include metals, ceramics, polymers and composite structures. Furthermore, according to the World Health Organization (WHO), oral diseases are among the most expensive diseases to be treated in developing as well as developed countries. Moreover, the new era of biomaterials and biomaterial engineering including regenerative medicine and applications are numerous in the modern dentistry. On the basis of these considerations, new biomaterials and technologies are playing the key role in the development of dental biomaterials market globally.
The dental biomaterials market is driven by various factor such growing technological advancements, increase in prevalence of dental disorders and oral hygiene awareness among the people. Furthermore, there has been an increase in the number of dental implants and oral surgeries due to the growing age population and rise in spending on cosmetic dentistry is boosting the demand for dental biomaterials market globally. The dental biomaterials market witness a significant growth, owing to the rising dental tourism and growing middle-class population in developing countries. However, stringent regulatory and clinical processes and the high unawareness about the advantages of dental biomaterials across the regions can hamper the growth of the global dental biomaterials market.
The dental biomaterials market is segmented by type, application, end user and geography
In terms of type, the dental biomaterials market is segmented into metallic biomaterials, ceramic biomaterials, polymeric biomaterials, metal-ceramic biomaterials and natural biomaterials. The metallic biomaterials is further sub segmented into titanium, stainless steel, chromium alloys and other metallic biomaterials. The large share of metallic biomaterials segment can be attributed to the increasing penetration of dental implants and the wide applications of metallic biomaterials in dentistry.
The various applications of the dental biomaterials market are covered in the report such as implantology, prosthodontics, orthodontics and other applications. The increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry are factors rising the demand for implantology application segment globally.
Based on end user, the dental biomaterials market is segmented into dental product manufacturers, laboratories, hospitals & clinics and academies & research institutes. Among these hospitals & clinics segment dominated the market in 2018, owing to the implementation of improved technologies. Furthermore, there are many areas of research that biomaterials and dental stem cells were used. They offer potential for tissue regeneration in dentin, periodontal ligament, dental pulp, and even enamel. Also the use of dental stem cells as sources of cells to facilitate repair of nondental tissues such as bone and nerves has been introduced.
The report is studied across key countries of various regions such as, North America, Europe, Asia-Pacific and rest of the world region which includes Latin America and MEA. The North America accounted for the largest share of the market in 2018, due to the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants.
The prominent market players operating in the world are Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd., Medtronic PLC, Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex PLC, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd., Bego Medical GmbH and Cam Bioceramics B.V.. Various strategies, such as expansions, joint ventures, mergers & acquisitions and others have been applied by key manufacturers to gain stronghold of the market.
July 2018: The Straumann Group acquired a 30% stake in its biomaterials partner botiss medical AG for an undisclosed sum. botiss is a fast-growing, entrepreneurial company that has already become a leading provider of biomaterials for oral surgery. The acquisition agreement enables Straumann to expand its global distribution network of botiss products
July 2018: Carpenter Technology Corporation announced plans for adding an Emerging Technology Center on its Athens, Alabama campus. The facility initially focus on Additive Manufacturing (AM) technology development, with future investments slated for soft magnetics and meltless titanium powder
September 2018: Henry Schein, Inc., announced three investments that will advance the Company’s dental implant business strategy. This will enhance its position in the premium implant segment through the acquisition of Intra-Lock, a provider of dental restoration solutions, including proprietary surface, connection, and biomaterial and small diameter implant technologies; expand into the lower-priced segment of the dental implant market through the planned acquisition of a majority interest in Medentis Medical.
The dental biomaterials market is segmented by type, application, end user and geography. In terms of type, the dental biomaterials market is segmented into metallic biomaterials, ceramic biomaterials, polymeric biomaterials, metal-ceramic biomaterials and natural biomaterials. The metallic biomaterials is further sub segmented into titanium, stainless steel, chromium alloys and other metallic biomaterials. The large share of metallic biomaterials segment can be attributed to the increasing penetration of dental implants and the wide applications of metallic biomaterials in dentistry.
Based on applications, the dental biomaterials market is classified into implantology, prosthodontics, orthodontics and other applications. The increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry are factors rising the demand for implantology application segment globally.
By end user, the dental biomaterials market is segmented into dental product manufacturers, laboratories, hospitals & clinics and academies & research institutes. Among these hospitals & clinics segment dominated the market in 2018, owing to the implementation of improved technologies.
Geographically the market is segmented into North America, Europe, Asia-Pacific and rest of the world region which includes Latin America and MEA. The Europe accounted for the largest share of the market in 2018, due to the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants.
Why to buy this report:
